“In the current and prior periods, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.”10-Q · Aug 3, 2026 ↗
Boston Scientific Corporation
BSX
Market read
Boston Scientific Corporation's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 26 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 14 directly disclosed connections are confirming.
- BSX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if BSX's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 26 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 14 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- BSX's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +19.9% year over year.
- Operating margin changed +2.5 percentage points in the latest annual period.
- Foreign exchange has repeated favorable evidence across 4 filings.
No qualifying adverse evidence was identified; that is not proof there is no downside.
No credible peer-relative valuation comparison is available yet.
Price as of Sep 10, 2026
43.10Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“Organic net sales growth excludes the impact of foreign currency fluctuations and net sales attributable to certain acquisitions and divestitures for which there are less than a full period of comparable net sales.”10-Q · Aug 3, 2026 ↗
“49 Table of Content s Interest Expense The following table provides a summary of our Interest expense and average borrowing rate: Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Interest expense (in millions) $ (87) $ (79)…”10-Q · Nov 3, 2025 ↗
“In the first nine months of 2025, the primary factors that impacted gross profit margin were inventory charges of approximately $90 million resulting from the global discontinuation of the ACURATE platform, increased levels of tariffs and other period expense…”10-Q · Nov 3, 2025 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 3.2× · EV/sales 3.1×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:10 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for BSX. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for BSX. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind BSX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
PENPenumbra, Inc.investeeMay 1, 2026 ▾
“37 Table of Contents Contractual Obligations and Commitments On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc.”
Depended on by
IRTCiRhythm Holdings, Inc.competitorApr 30, 2026 ▾
“In providing our iRhythm Services, we compete with BioTelemetry, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 19 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
BSX is currently a Follower in the organic co-movement group High-Beta Growth. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.